Ligand‐based design of a potent inhibitor of NUPR1 exerting anticancer activity via necroptosis

P. Santofimia‐Castaño, Y. Xia, W. Lan, Z. Zhou, C. Huang, L. Peng, P. Soubeyran, A. Velazquez‐Campoy, O. Abian, B. Rizzuti, J.L. Neira, J. Iovanna. Ligand‐based design of a potent inhibitor of NUPR1 exerting anticancer activity via necroptosis. Journal of Clinical Investigation 2019 129:2500-2513
Impact factor: 
12,28